نتایج جستجو برای: bone marrow transplant bmt

تعداد نتایج: 368674  

Journal: :Blood 2000
R E Clark A J Flory E M Ion B E Woodcock B H Durham W D Fraser

The effect of high-dose chemotherapy and autografting on bone turnover in myeloma is not known. A study of 32 myeloma patients undergoing blood or marrow transplant (BMT), conditioned with high-dose melphalan, was done. Bone resorption was assessed by urinary free pyridinoline (fPyr) and deoxypyridinoline (fDPyr), expressed as a ratio of the urinary creatinine concentration. Bone formation was ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998
A Humar S Wood J Lipton H Messner J Meharchand A McGeer K MacDonald T Mazzulli

The effect of cytomegalovirus (CMV) infection on 1-year mortality rates among allogeneic bone marrow transplant recipients who are receiving a standard protocol as prophylaxis for CMV infection is unclear. We determined the risk factors for death within 1 year among 103 bone marrow transplant recipients by performing a multivariate analysis. The results of donor and recipient CMV serologies did...

2000
Richard E. Clark Angela J. Flory Edwina M. Ion Barry E. Woodcock Brian H. Durham

The effect of high-dose chemotherapy and autografting on bone turnover in myeloma is not known. A study of 32 myeloma patients undergoing blood or marrow transplant (BMT), conditioned with high-dose melphalan, was done. Bone resorption was assessed by urinary free pyridinoline (fPyr) and deoxypyridinoline (fDPyr), expressed as a ratio of the urinary creatinine concentration. Bone formation was ...

Journal: :acta medica iranica 0
a. khodabeh. p.nasseri. m jahani. a.ghavamzadeh. i. baybordi. m. mohyeddin. g. ghahremani

nineteen patterns with cml have been transplanted in our bone marrow transplantation (bmt) section since 1991, the mean age of these patients was 26.05 (sd = 9.35). our conditioning regimen for these patients was cyclophosphamide 60mglkg for 2 days and busulfan 4mglkg for 4 consecutive days. eleven patients are still alive arid eight patients died during follow-up ranging from 6 months to 5 yea...

1982
Claudia A Montiel-Equihua Adrian J Thrasher H Bobby Gaspar

A 4-month-old male received a T-lymphocyte-depleted haploidentical bone marrow transplant (BMT) for correction of severe combined immunodeficiency (SCID) due to adenosine deaminase (ADA) deficiency. Although previous haploidentical bone marrow transplants have been attempted in ADA-deficient SCID, complete reconstitution of both B-lymphocyte and T-lymphocyte function has not been obtained after...

Journal: :Journal of the American Society of Nephrology : JASN 2008
Kan Katayama Mitsuo Kawano Ichiro Naito Hitoshi Ishikawa Yoshikazu Sado Nagisa Asakawa Tomohiro Murata Kazuki Oosugi Michiyo Kiyohara Eiji Ishikawa Masaaki Ito Shinsuke Nomura

Alport syndrome is a hereditary nephropathy that results in irreversible, progressive renal failure. Recent reports suggested that bone marrow transplantation (BMT) has a beneficial, short-term effect on renal injury in Alport (Col4a3(-/-)) mice, but its long-term effects, especially with regard to survival, are unknown. In this study, Alport mice received a transplant of either wild-type or Co...

Journal: :Haematologica 2005
Norbert Schmitz Meral Beksac Andrea Bacigalupo Tapani Ruutu Arnon Nagler Eliane Gluckman Nigel Russell Jane Apperley Jeff Szerm Kenneth Bradstock Agnes Buzyn Brigitte Schlegelberger James Matcham Alois Gratwohl

BACKGROUND AND OBJECTIVES Allogeneic peripheral blood progenitor cells (PBPC) are now widely used as the source of hematopoietic stem cells for transplantation. However, it is still not clear which patients should receive mobilized PBPC or bone marrow cells to reconstitute hematopoiesis after myeloablative conditioning. The aim of this study is to present 3-year-follow-up data on outcome (incid...

Journal: :Haematologica 1999
P Perutelli F Lerzo G Calza M Cevasco P G Mori

chio M, Porta F. Rapid regeneration of normally functional naive CD4+ T-cells after bone marrow transplantation from unrelated donors for combined immunodeficiency. Blood 1998; 92:3484-6. 7. Mackall CL, Hakim FT, Gress RE. T-cell regeneration: all repertoires are not created equal. Immunol Today 1997; 18:245-51. 8. Dickinson AM, Reid MM, Abinum M, et al. In vitro T cell depletion using Campath ...

Journal: :The Yale Journal of Biology and Medicine 1990
C. M. Poliquin

Increasingly, bone marrow transplant (BMT) is the treatment of choice for certain hematologic diseases. BMT is, however, a risky procedure with many potentially serious complications. Some complications are the result of the conditioning regimen, a stage of transplantation that includes large doses of chemotherapy and/or radiation therapy. Conditioning-induced neutropenia and thrombocytopenia o...

Journal: :Journal of paediatrics and child health 2011
Aric Bendorf Ian H Kerridge

In the 50 years since the first successful human bone marrow transplant (BMT) was performed in 1959, BMT has become the optimal therapy for a wide variety of life-threatening paediatric haematological, immunological and genetic disorders. Unfortunately, while BMT generally provides the only possibility of cure for such afflicted children, few (25%) have a matched sibling available, and suitably...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید